BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$6.17B |
| 2 |
United Parcel Service
UPS
|
+$1.31B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$1.2B |
| 4 |
Unilever
UL
|
+$1.12B |
| 5 |
Morgan Stanley
MS
|
+$972M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.6B |
| 2 |
Pfizer
PFE
|
+$1.47B |
| 3 |
UN
Unilever NV New York Registry Shares
UN
|
+$1.22B |
| 4 |
IMMU
Immunomedics Inc
IMMU
|
+$1.14B |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.72% |
| 2 | Healthcare | 13.84% |
| 3 | Financials | 12.09% |
| 4 | Consumer Discretionary | 11.96% |
| 5 | Communication Services | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3426
Eton Pharmaceutcials
ETON
$1.27B
| $8.56M | ﹤0.01% |
1,052,945
+59,350
| +6% | +$458K |
|
|
KLDO
3427
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
| $8.54M | ﹤0.01% |
938,631
+404,988
| +76% | +$3.32M |
|
3428
MoonLake Immunotherapeutics
MLTX
$1.57B
| $8.53M | ﹤0.01% |
+750,153
| New | +$7.96M |
|
3429
Mistras Group
MG
$484M
| $8.52M | ﹤0.01% |
1,097,972
+18,585
| +2% | +$96.9K |
|
|
ALR
3430
DELISTED
AlerisLife Inc
ALR
| $8.51M | ﹤0.01% |
1,233,665
+50,922
| +4% | +$295K |
|
3431
Gyre Therapeutics
GYRE
$641M
| $8.5M | ﹤0.01% |
179,653
+9,454
| +6% | +$409K |
|
|
ESXB
3432
DELISTED
Community Bankers Trust Corporation
ESXB
| $8.49M | ﹤0.01% |
1,258,259
+44,162
| +4% | +$270K |
|
3433
Marathon Digital Holdings
MARA
$4.32B
| $8.45M | ﹤0.01% |
809,079
+808,777
| +267,807% | +$3.73M |
|
3434
iShares Global Infrastructure ETF
IGF
$10.9B
| $8.43M | ﹤0.01% |
192,753
-453,444
| -70% | -$19M |
|
3435
Norwood Financial Corp
NWFL
$370M
| $8.41M | ﹤0.01% |
321,585
+28,063
| +10% | +$735K |
|
3436
iShares ESG Advanced MSCI EM ETF
EMXF
$160M
| $8.39M | ﹤0.01% |
+200,000
| New | +$7.9M |
|
|
IMDX
3437
Insight Molecular Diagnostics
IMDX
$150M
| $8.37M | ﹤0.01% |
175,102
+10,433
| +6% | +$383K |
|
|
PZN
3438
DELISTED
Pzena Investment Management, Inc. Class A
PZN
| $8.37M | ﹤0.01% |
1,146,256
-13,414
| -1% | -$85K |
|
|
PFHD
3439
DELISTED
Professional Holding Corp. Class A Common stock
PFHD
| $8.36M | ﹤0.01% |
541,952
+39,440
| +8% | +$575K |
|
|
MPX
3440
DELISTED
Marine Products Corp
MPX
| $8.36M | ﹤0.01% |
575,124
-3,479
| -0.6% | -$57.4K |
|
3441
PUT
iShares MSCI Brazil ETF
EWZ
$9.28B
| $8.34M | ﹤0.01% |
+225,000
| New | +$7.26M |
|
3442
Curis
CRIS
$9.78M
| $8.33M | ﹤0.01% |
2,544
+1,478
| +139% | +$1.77M |
|
3443
Texas Pacific Land
TPL
$27.8B
| $8.32M | ﹤0.01% |
103,014
+6,705
| +7% | +$425K |
|
3444
Verrica Pharmaceuticals
VRCA
$89.7M
| $8.28M | ﹤0.01% |
71,889
+3,411
| +5% | +$313K |
|
3445
Fennec Pharmaceuticals
FENC
$332M
| $8.25M | ﹤0.01% |
1,107,204
+32,171
| +3% | +$245K |
|
3446
iShares iBonds Dec 2029 Term Corporate ETF
IBDU
$4.03B
| $8.25M | ﹤0.01% |
300,000
-45
| -0% | -$1.22K |
|
3447
Cardiff Oncology
CRDF
$66.5M
| $8.22M | ﹤0.01% |
457,201
+109,727
| +32% | +$1.93M |
|
3448
iShares US Technology ETF
IYW
$23.6B
| $8.2M | ﹤0.01% |
96,424
-56,392
| -37% | -$4.51M |
|
|
DMRA
3449
Damora Therapeutics, Inc. Ordinary Shares
DMRA
$1.78B
| $8.19M | ﹤0.01% |
+26,195
| New | +$9.74M |
|
3450
Nuvation Bio
NUVB
$2.2B
| $8.19M | ﹤0.01% |
+700,000
| New | +$7.28M |
|
Similar funds
BlackRock's Q4 2020 Portfolio in Review
As of Q4 2020, BlackRock held 5,303 positions worth $3.13T, up 16% from $2.71T the previous quarter. Its ten largest holdings account for 18% of the portfolio.
BlackRock's Q4 2020 filing shows 229 new, 3,197 increased, 1,165 reduced and 227 closed positions. Its largest new stake was Apartment Income REIT Corp.: 16,793,824 shares worth $645M. The largest sale was Apple, an estimated $1.6B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q4 2020 buy was Apartment Income REIT Corp.: 16,793,824 shares worth $645M.
- BlackRock added most to Tesla in Q4 2020, an estimated $6.17B increase.
- BlackRock's biggest Q4 2020 reduction was Apple, cutting an estimated $1.6B.
- BlackRock fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $1.22B.
- BlackRock's ten largest holdings make up 18% of its $3.13T portfolio in Q4 2020.
- BlackRock opened 229 new positions and closed 227 in Q4 2020.
- BlackRock's portfolio value rose 16% quarter-over-quarter to $3.13T.
Based on BlackRock's 13F filing for Q4 2020, filed 5 Feb 2021.